Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

Not Applicable

Completed

• Conditions: Cancer
• Interventions: Device: Handheld Device (Smart Phone)

• Registration Number: NCT03196050
• Lead Sponsor: Universitätsmedizin Mannheim

Brief Summary

Cancer is becoming a chronic disease, with the requirement of a lifelong intake of cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer patients may require a more customized and tailored follow up.

Most elderly patients have multiple other diseases ("comorbidities") and, due to many other factors, may per se not tolerate or simply not follow anticancer therapies. This may not only impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival).

Handheld devices provide a new reporting/communication tool for patients and health care providers. TeleGraPH will assess if these devices are a suitable communication modality in a cohort of geriatric cancer patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11
• Study First Submitted: 2017-06-20
• Study First Submitted QC: 2017-06-20
• Study First Posted: 2017-06-22
• Primary Completion: 2018-12
• Study Completion: 2018-12
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-21
• Last Update Posted: 2019-01-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age > 60 years
• Karnofsky Performance Status ≥ 70
• histologically confirmed malignant tumor (cancer)

Exclusion Criteria

• concurrent severe and/or uncontrolled concomitant medical conditions
• Patients unwilling or unable to comply with using a handheld device

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Telemonitoring using a handheld device	Handheld Device (Smart Phone)	Patients will be euqipped with either an app or a handheld device with a pre-installed app to communicate with the coordinating center.

Primary Outcome Measures

Name	Time	Method
Device Adherence/Compliance	1 Year	Frequency of using the handheld device and of daily/weekly/monthly reportings

Secondary Outcome Measures

Name	Time	Method
Quality of Life	1 Year	Assessed using the EORTC QLQ-C30 questionnaire
Reliability of reports	1 Year	Patient-reported status will be compared to physician-rated status

Trial Locations

Locations (1)

Department of Radiotherapy University Hospital Mannheim; 🇩🇪 Mannheim, Germany